Total joint replacement: a consideration for antimicrobial prophylaxis.

Area of Science:

• Orthopedics
• Infectious Diseases
• Pharmacology

Background:

• Total joint replacement infections are a major complication, leading to severe patient outcomes and high healthcare costs.
• Staphylococcus aureus and Staphylococcus epidermidis are the primary pathogens responsible for late prosthetic joint infections.
• Animal studies demonstrate that prosthetic joints are susceptible to infection through hematogenous seeding during transient bacteremia.

Purpose of the Study:

• To evaluate the efficacy of oral cephalosporins in preventing metastatic infections of prosthetic joints.
• To identify optimal antibiotic prophylaxis for patients undergoing dental procedures who are at risk for prosthetic joint infection.

Main Methods:

• Review of existing literature on prosthetic joint infections and antibiotic prophylaxis.
• Analysis of animal study findings regarding hematogenous seeding of prosthetic joints.
• Assessment of cephalosporin and clindamycin efficacy and safety profiles.

Main Results:

• Cephalosporins are established agents for perioperative and intraoperative infection prevention in total joint replacement.
• Oral cephalosporins are effective in minimizing the risk of prosthetic joint infection from transient dental bacteremias.
• Clindamycin serves as a suitable alternative for patients with cephalosporin or penicillin allergies.

Conclusions:

• Oral cephalosporins are the preferred prophylactic agents for preventing prosthetic joint infections associated with dental bacteremia.
• Antibiotic selection should consider patient allergies and potential cross-reactivity.
• Effective prophylaxis is essential to mitigate the devastating consequences of prosthetic joint infections.